Cobenfy represents a breakthrough schizophrenia treatment with a novel mechanism, but limited long-term data requires cautious adoption and patient-centered decision-making in clinical practice.

Some people who took a new schizophrenia drug for a year improved with only a few side effects, but many dropped out of the research, the company announced Thursday. The results underscore the difficulties in treating schizophrenia, a severe mental illness ...

Federal policies designed to reduce use of antipsychotic medications in nursing homes did not lead to clinically significant higher rates of schizophrenia diagnoses among residents and patients living with dementia, according to a new study published in ...

CT-155 is a smartphone app that integrates psychosocial interventions delivered using an adaptive goal-setting technique. A phase 3 trial has demonstrated that it can reduce the negative symptoms of schizophrenia.

Schizophrenia can be a commonly misunderstood illness, in part due to a great deal of misinformation, which can lead to potentially damaging stigma for the estimated 2.4 million adults in the United States living with it. On top of that, the stigma ...